Leqembi 62856-0212-01

Generic: Lecanemab

Package NDC

62856-0212-01

Manufacturer: Eisai Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: January 6, 2023
Listing Expires: December 31, 2027
Application: BLA761269

Need to source Leqembi? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lecanemab	100 mg/mL

Drug Class

Amyloid Beta-directed Antibody [EPC]Amyloid Beta-directed Antibody Interactions [MoA]Amyloid Beta-directed Antibody [EPC]

Selected Package

62856-0212-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01) / 2 mL in 1 VIAL, SINGLE-DOSE